148 related articles for article (PubMed ID: 16523396)
1. American Association for the Study of Liver Diseases (AASLD)--56th Annual Meeting.
Phend C
IDrugs; 2006 Feb; 9(2):96-100. PubMed ID: 16523396
[No Abstract] [Full Text] [Related]
2. HEP DART 2005 -- frontiers in drug development for viral hepatitis.
Feitelson MA
IDrugs; 2006 Mar; 9(3):165-7. PubMed ID: 16523376
[No Abstract] [Full Text] [Related]
3. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
[No Abstract] [Full Text] [Related]
4. Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.
Davis GL; Keeffe EB
Rev Gastroenterol Disord; 2001; 1(1):42-7. PubMed ID: 12120119
[No Abstract] [Full Text] [Related]
5. Viral hepatitis at a crossroad.
Lok AS; Pawlotsky JM
Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
[No Abstract] [Full Text] [Related]
6. Recent advances in antiviral agents: established and innovative therapies for viral hepatitis.
Balsano C
Mini Rev Med Chem; 2008 Apr; 8(4):307-18. PubMed ID: 18473923
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
Buti M
IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
[No Abstract] [Full Text] [Related]
8. [Treatment of hepatitis B and C -- current standards].
Zeuzem S
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
[No Abstract] [Full Text] [Related]
9. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
Kohli A
Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
[No Abstract] [Full Text] [Related]
10. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia.
Sherman KE; Shah VH
Gastroenterology; 2018 Feb; 154(3):453-456. PubMed ID: 29154778
[No Abstract] [Full Text] [Related]
11. Highlights from the 60th Annual Meeting of the AASLD.
Mayor S
Lancet Infect Dis; 2010 Jan; 10(1):8. PubMed ID: 20162852
[No Abstract] [Full Text] [Related]
12. Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy.
Yao N; Hong Z; Lau JY
Gastroenterology; 2002 Oct; 123(4):1350-63. PubMed ID: 12360496
[No Abstract] [Full Text] [Related]
13. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
14. [Hepatology 2009].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1335-9. PubMed ID: 19517326
[No Abstract] [Full Text] [Related]
15. 18th International Conference on Antiviral Research. Antivirals.
Kibble A
IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
[No Abstract] [Full Text] [Related]
16. [The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Pár A; Pár G
Orv Hetil; 2008 Jul; 149(28):1329-32. PubMed ID: 18617461
[No Abstract] [Full Text] [Related]
17. Perspective: incision revision.
Schwartz M
Nature; 2014 Dec; 516(7529):S17. PubMed ID: 25470196
[No Abstract] [Full Text] [Related]
18. [Congress of the European Association for the Study of the Liver].
Pár A
Orv Hetil; 2006 Sep; 147(38):1850-2. PubMed ID: 17066603
[No Abstract] [Full Text] [Related]
19. Virology of hepatitis B and C viruses and antiviral targets.
Pawlotsky JM
J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
Berenguer M; Wright TL
Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
